Market Research Logo

Global Veterinary Clostridium Vaccine Market 2017-2021

Global Veterinary Clostridium Vaccine Market 2017-2021

About Veterinary Clostridium Vaccine

Clostridium bacteria are widely found in soil and the guts of various animals. These microbes are anaerobic in nature and produce a wide range of toxins leading to various diseases in animals. Some of these diseases are zoonotic in nature. Vaccines play a major role in protecting the animals against all the Clostridia diseases. Various types of vaccines are available, either in a single form or in combinations, which consist of bacterins, toxoids, or mixtures of bacterins and toxoids.

Technavio’s analysts forecast the global veterinary clostridium vaccine market to grow at a CAGR of 4.96% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global veterinary clostridium vaccine market for 2017-2021. To calculate the market size, the report considers sales of Clostridium vaccines.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Veterinary Clostridium Vaccine Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Elanco
  • Merck
  • Merial (now part of Boehringer Ingelheim)
  • Zoetis
Other prominent vendors
  • Advaxis
  • AMPLIPHI
  • Aratana Therapeutics
  • ARKO Labs
  • Bayer
  • CanFel Therapeutics
  • Ceva
  • Colorado Serum Company
  • Epitopix
  • Genus
  • Hygieia Biological Laboratories
  • NEXVET
  • Nuovo Biologics
  • Valneva SE
  • Vetoquinol
  • Virbac
Market driver
  • Advances in technology
  • For a full, detailed list, view our report
Market challenge
  • Manufacturing and storage issues
  • For a full, detailed list, view our report
Market trend
  • Inorganic growth strategies
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Veterinary Clostridium Vaccine Market 2017-2021

Technavio recognizes the following companies as the key players in the global veterinary clostridium vaccine market: Elanco, Merck, Merial (now part of Boehringer Ingelheim), and Zoetis.

Other Prominent Vendors in the market are: Advaxis, AMPLIPHI, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva, Colorado Serum Company, Epitopix, Genus, Hygieia Biological Laboratories, NEXVET, Nuovo Biologics, Valneva SE, Vetoquinol, and Virbac.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is inorganic growth strategies. The veterinary Clostridium vaccine market has been witnessing an increasing trend in strategic alliances and acquisitions among vendors. The vendors are planning for inorganic growth strategies such as acquisitions and partnerships to boost the research and to improve its penetration in emerging markets.”

According to the report, one driver in the market is advances in technology. The advances in technology have improved the overall pharmacokinetics and dynamics of vaccines along with cost-effective processes. The use of cell line culture in manufacturing viral vaccinations has been increased, which improved the quality of vaccinations. For instance, Valneva SE developed EB66 cell line, which can be used for high-efficiency vaccine production. This cell line is derived from stem cells of duck embryo. This can be used for large-scale manufacturing of veterinary vaccines.

Further, the report states that one challenge in the market is manufacturing and storage issues. A vaccine involves a complex network of processes ranging from manufacturing to delivery. The cost-intensive manufacturing issues associated with vaccines get quadrupled with strict regulatory laws. The protocol set by the FAO for manufacturing animal vaccines has rigorous processes like master seed and master stock analysis. These processes are crucial to producing quality vaccines, as they involve analysis of microbes, which are used in vaccine manufacturing followed by sterilization process and storage process.

Companies Mentioned

Elanco, Merck, Merial (now part of Boehringer Ingelheim), Zoetis, Advaxis, AMPLIPHI, Aratana Therapeutics, ARKO Labs, Bayer, CanFel Therapeutics, Ceva, Colorado Serum Company, Epitopix, Genus, Hygieia Biological Laboratories, NEXVET, Nuovo Biologics, Valneva SE, Vetoquinol, and Virbac.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
  • An overview of Clostridial Disease
    • Table Various clostridial diseases in animals
  • Market landscape
    • Market overview
      • Table Global veterinary Clostridium vaccine market snapshot
      • Table Global veterinary Clostridium vaccine market 2016-2021 ($ millions)
      • Table Opportunity analysis in global veterinary Clostridium vaccine market
    • Five forces analysis
      • Table Five forces analysis
  • Market segmentation by species type
    • Table Market segmentation by type of species 2016
    • Swine
      • Table Global Clostridium swine vaccine market 2016-2021 ($ millions)
    • Bovine
      • Table Species of Clostridium microbes affecting bovine animals
      • Table Global Clostridium bovine vaccine market 2016-2021 ($ millions)
      • Table Various commonly reported clostridial diseases in bovine animals
    • Poultry
      • Table Global Clostridium poultry vaccine market 2016-2021 ($ millions)
    • Others
      • Table Examples of few major animals from the segment
      • Table Global veterinary Clostridium vaccine market by other species 2016-2021 ($ millions)
  • Geographical segmentation
    • Table Segmentation of global veterinary Clostridium vaccine market by geography 2016 and 2021 (%)
    • Table Global veterinary Clostridium vaccine market by geography 2016-2021 ($ millions)
    • Veterinary Clostridium vaccine market in Americas
      • Table Market scenario in Americas
      • Table Veterinary Clostridium vaccine market in Americas 2016-2021 ($ millions)
    • Veterinary Clostridium vaccine market in EMEA
      • Table Market scenario in EMEA
      • Table Veterinary Clostridium vaccine market in EMEA 2016-2021 ($ millions)
    • Veterinary Clostridium vaccine market in APAC
      • Table Market scenario in APAC
      • Table Veterinary Clostridium vaccine market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Major factors for CVB product approval
  • Market trends
    • Inorganic growth strategies
      • Table Recent strategic alliances in animal healthcare
    • Combination vaccines
      • Table USDA approved combination vaccines
    • Industry-academia collaborations
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global veterinary Clostridium vaccine market 2016
      • Table Competitive factors of global veterinary Clostridium vaccine market
    • Competitive landscape analysis
      • Table Market penetration of various veterinary Clostridium vaccine manufacturers worldwide 2016
      • Table Strategic success factors of companies in global veterinary Clostridium vaccine market
  • Key vendor analysis
    • Elanco
      • Table Elanco: Key highlights
      • Table Elanco: Strength assessment
      • Table Elanco: Strategy assessment
      • Table Elanco: Opportunity assessment
    • Merck
      • Table Merck: Key highlights
      • Table Merck: Strength assessment
      • Table Merck: Strategy assessment
      • Table Merck: Opportunity assessment
    • Merial (now part of Boehringer Ingelheim)
      • Table Merial: Key highlights
      • Table Merial: Strength assessment
      • Table Merial: Strategy assessment
      • Table Merial: Opportunity assessment
    • Zoetis
      • Table Zoetis: Key highlights
      • Table Zoetis: Strength assessment
      • Table Zoetis: Strategy assessment
      • Table Zoetis: Opportunity assessment
    • Other prominent vendors
      • Table Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report